Durable survival with TRIDENT in treatment-naïve advanced NSCLC In our prospective phase I clinical trial ...
c-Jun overexpression fails to prevent CAR T cell exhaustion in tumors, but PD-L1 blockade restores ...
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and ...
PCs are enriched in clinical responders to PD-1 blockade To test the hypothesis that B ...